ClinicalMetric / Countries / Czech Republic / acute lymphoblastic leukemia
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

acute lymphoblastic leukemia Clinical Trials in Czech Republic

Active clinical trials for acute lymphoblastic leukemia with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (1)

NCT05748171 Phase 2
Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Enrollment
100 pts
Country
🇨🇿 Czech Republic
Pfizer
View Trial →

Frequently Asked Questions

How many acute lymphoblastic leukemia clinical trials are active in Czech Republic?
There are currently 1 active clinical trials for acute lymphoblastic leukemia with sites in Czech Republic, of which 1 are actively recruiting patients.
How can I join a acute lymphoblastic leukemia clinical trial in Czech Republic?
To join a acute lymphoblastic leukemia clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute lymphoblastic leukemia trials in Czech Republic?
Active acute lymphoblastic leukemia trials in Czech Republic span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global acute lymphoblastic leukemia Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology